Ondametic 4mg

SF0426OA6643/072026
13/07/2028

Active ingredient:
Ondansetron 4 mg.

Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).

Dosage form
Solution for injection.

Click here to download full Insert leaflet

UR-AID N

Active ingredient:Piperazine citrate 171 mg Colchicine 0.5 mg. Therapeutic...

Bi-Ketogesic 150 mg

Active ingredient:150mg Ketoprofen Therapeutic indications:Indicated as Analgesic, anti-inflammatory. Dosage...

صورة أدوية أوميز Omez لعلاج الحموضة وارتجاع المرئ

Omez 40 mg Vial

Active ingredient:Omeprazole 40 mg. Therapeutic indications:Indicated for treatment of...

Contact Us

Ondametic 4mg

UR-AID N

Bi-Ketogesic 150 mg

Omez 40 mg Vial

COMMITED TO
QUALITY CARE

Contact Us

Ondametic 4mg

UR-AID N

Bi-Ketogesic 150 mg

Omez 40 mg Vial

COMMITED TOQUALITY CARE

COMMITED TO
QUALITY CARE